Sorafenib-RT in Treating Hepatocellular Carcinoma (SHEP)

NCT00892658 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Sorafenib

Sponsor

University Health Network, Toronto